Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Alogliptin + Metformin & Type 2 Diabetes (T2D), in January 2013, the FDA approved Alogliptin + Metformin as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes (T2D).
The EMA authorized Alogliptin + Metformin for adults with T2D whose hyperglycemia is not adequately controlled on previous treatments, when both components are indicated.
[Vipdome…